Nicotinamide Adenine Dinucleotide Market Analysis

In terms of grade, nicotinamide adenine dinucleotide market is categorized into food grade pharmaceutical grade, and others. The pharmaceutical grade is expected to surpass USD 515 million in revenue by 2030 as a result of numerous benefits of the product as an anti-depressant, an anti-aging solution, and for improving cell restoration, bolstering the inclusion of NADH in many disease-curing drugs, thereby stimulating the demand for the pharmaceutical grade of the nicotinamide adenine dinucleotide globally.

In terms of application, nicotinamide adenine dinucleotide market is segregated into dietary supplements, pharmaceuticals, anti-aging products, and others. Anti-aging products segment was valued at more than USD 110 million in 2021 and is estimated to progress at 14.5% CAGR over the next 8 years as NAD+ anti-aging products are used to treat rosacea, pigmentation, fine lines, wrinkles, and acne. The rising popularity of skincare and cosmetics products, along with the surging awareness of the advantages of NAD supplements.

Nicotinamide adenine dinucleotide market is segmented into Europe, Asia Pacific, North America, the Middle East & Africa, and Latin America. The Europe NAD market is anticipated to reach over USD 330 million in revenue by 2030. The surging consumer interest in anti-aging products containing nicotinamide adenine dinucleotide in is propelling regional market demand. In addition, the strong presence of pharmaceutical manufacturers that are providing advanced functional beverage products is speculated to augment the regional industry expansion.